Cargando…
Culprit Medications and Risk Factors Associated with Stevens–Johnson Syndrome and Toxic Epidermal Necrolysis: Population-Based Nested Case–Control Study
OBJECTIVE: Our objective was to describe the incidence of Stevens–Johnson syndrome/toxic epidermal necrolysis (SJS/TEN) in a large unselected cohort, to validate the culprit drugs involved and the frequency of SJS/TEN for each drug, and to analyze the clinical risk factors for SJS/TEN. METHODS: Usin...
Autores principales: | Gronich, Naomi, Maman, David, Stein, Nili, Saliba, Walid |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer International Publishing
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8814784/ https://www.ncbi.nlm.nih.gov/pubmed/35119606 http://dx.doi.org/10.1007/s40257-021-00661-0 |
Ejemplares similares
-
Toxic epidermal necrolysis and Stevens-Johnson syndrome
por: Harr, Thomas, et al.
Publicado: (2010) -
Stevens–Johnson Syndrome and Toxic Epidermal Necrolysis
por: Klimas, Natasha, et al.
Publicado: (2015) -
Stevens–Johnson syndrome/toxic epidermal necrolysis associated with zonisamide
por: Vivar, Karina L., et al.
Publicado: (2017) -
The Epidemiology of Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis in China
por: Yang, Shang-Chen, et al.
Publicado: (2018) -
Ampicillin/sulbactam: Stevens-Johnson syndrome/toxic epidermal necrolysis
Publicado: (2021)